These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 11983761)

  • 1. The hypocretin/orexin system.
    Ebrahim IO; Howard RS; Kopelman MD; Sharief MK; Williams AJ
    J R Soc Med; 2002 May; 95(5):227-30. PubMed ID: 11983761
    [No Abstract]   [Full Text] [Related]  

  • 2. Sleep, feeding, and neuropeptides: roles of orexins and orexin receptors.
    Mieda M; Yanagisawa M
    Curr Opin Neurobiol; 2002 Jun; 12(3):339-45. PubMed ID: 12049942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Involvement of orexins/hypocretins in multiple physiological functions].
    Ueta Y
    J UOEH; 2001 Jun; 23(2):147-59. PubMed ID: 11431960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Orexins and orexin receptors].
    Kotaska K; Průsa R
    Cesk Fysiol; 1999 Aug; 48(3):119-21. PubMed ID: 10568074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypocretin/orexin: maintenance of wakefulness and a multiplicity of other roles.
    Kilduff TS
    Sleep Med Rev; 2005 Aug; 9(4):227-30. PubMed ID: 15998593
    [No Abstract]   [Full Text] [Related]  

  • 6. Narcolepsy: a key role for hypocretins (orexins).
    Siegel JM
    Cell; 1999 Aug; 98(4):409-12. PubMed ID: 10481905
    [No Abstract]   [Full Text] [Related]  

  • 7. Normal plasma levels of orexin A (hypocretin-1) in narcoleptic patients.
    Dalal MA; Schuld A; Haack M; Uhr M; Geisler P; Eisensehr I; Noachtar S; Pollmächer T
    Neurology; 2001 Jun; 56(12):1749-51. PubMed ID: 11425946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Orexins and the treatment of obesity.
    Smart D; Haynes AC; Williams G; Arch JR
    Eur J Pharmacol; 2002 Apr; 440(2-3):199-212. PubMed ID: 12007536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Orexins: from neuropeptides to energy homeostasis and sleep/wake regulation.
    Beuckmann CT; Yanagisawa M
    J Mol Med (Berl); 2002 Jun; 80(6):329-42. PubMed ID: 12072908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Narcolepsy and low CSF orexin (hypocretin) concentration after a diencephalic stroke.
    Scammell TE; Nishino S; Mignot E; Saper CB
    Neurology; 2001 Jun; 56(12):1751-3. PubMed ID: 11425947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The level of hypocretin 1 (orexin A) in cerebrospinal fluid and the diagnosis of narcolepsy and other somnolent disorders.
    Kunimoto M
    Intern Med; 2003 Aug; 42(8):634-5. PubMed ID: 12924483
    [No Abstract]   [Full Text] [Related]  

  • 12. Integrative physiology of orexins and orexin receptors.
    Mieda M; Sakurai T
    CNS Neurol Disord Drug Targets; 2009 Aug; 8(4):281-95. PubMed ID: 19689310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CSF hypocretin-1 (orexin-A) levels in childhood narcolepsy and neurologic disorders.
    Arii J; Kanbayashi T; Tanabe Y; Sawaishi Y; Kimura S; Watanabe A; Mishima K; Hishikawa Y; Shimizu T; Nishino S
    Neurology; 2004 Dec; 63(12):2440-2. PubMed ID: 15623725
    [No Abstract]   [Full Text] [Related]  

  • 14. Comments to the editor concerning the paper entitled "Orexin-A regulates body temperature in coordination with arousal status" by Yoshimichi et al.
    Aronoff DM
    Exp Biol Med (Maywood); 2002 Jan; 227(1):1-2; discussion 3. PubMed ID: 11788776
    [No Abstract]   [Full Text] [Related]  

  • 15. The role of the hypocretinergic system in the integration of networks that dictate the states of arousal.
    Winsky-Sommerer R; Boutrel B; De Lecea L
    Drug News Perspect; 2003 Oct; 16(8):504-12. PubMed ID: 14668948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Undetectable CSF level of orexin A (hypocretin-1) in a HLA-DR2 negative patient with narcolepsy-cataplexy.
    Dalal MA; Schuld A; Pollmächer T
    J Sleep Res; 2002 Sep; 11(3):273. PubMed ID: 12220324
    [No Abstract]   [Full Text] [Related]  

  • 17. CSF hypocretin/orexin levels in narcolepsy and other neurological conditions.
    Ripley B; Overeem S; Fujiki N; Nevsimalova S; Uchino M; Yesavage J; Di Monte D; Dohi K; Melberg A; Lammers GJ; Nishida Y; Roelandse FW; Hungs M; Mignot E; Nishino S
    Neurology; 2001 Dec; 57(12):2253-8. PubMed ID: 11756606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and functional analysis of mutations in the hypocretin (orexin) genes of narcoleptic canines.
    Hungs M; Fan J; Lin L; Lin X; Maki RA; Mignot E
    Genome Res; 2001 Apr; 11(4):531-9. PubMed ID: 11282968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The hypocretin/orexin system in health and disease.
    Nishino S
    Biol Psychiatry; 2003 Jul; 54(2):87-95. PubMed ID: 12873797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Orexin receptors and G-protein coupling: evidence for another "promiscuous" seven transmembrane domain receptor.
    Karteris E; Randeva HS
    J Pharmacol Sci; 2003 Sep; 93(1):126-8. PubMed ID: 14501163
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.